Skip to content

A Clinical Study on Ultrasound-Guided Acupoint catgut Embedding Therapy for Simple Obesity

A Clinical Study on Ultrasound-Guided Acupoint catgut Embedding Therapy for Simple Obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001260
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Simple Obesity

Interventions

Experimental Group:Ultrasound-Guided Acupoint catgut Embedding Therapy
Control Group:Traditional Acupoint catgut Embedding Therapy

Sponsors

Zigong First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1) Meets the diagnostic criteria for simple obesity as mentioned above; 2) Aged between 18 and 49 years old; 3) Willing to undergo three sessions of acupuncture point embedding therapy and sign an informed consent form; 4) Has not undergone any medical weight loss treatments in the past three months.

Exclusion criteria

Exclusion criteria: 1) Individuals with allergies to heterologous proteins; 2) Patients with diabetes, hyperlipidemia, coronary heart disease, polycystic ovary syndrome, cancer, gout, or other chronic diseases of the endocrine or autoimmune systems; 3) Individuals taking glucocorticoids, sex hormones, or those with secondary obesity due to other illnesses; 4) Pregnant or breastfeeding women; 5) Individuals with coagulation disorders, including those using anticoagulant or antiplatelet medications; 6) Individuals with impaired skin and subcutaneous tissue absorption or repair functions due to other diseases; 7) Individuals with skin diseases, inflammation, ulcers, or breaks at the acupuncture points where the thread is to be inserted; 8) Individuals unable to follow up on time; 9) Individuals deemed unsuitable for participation in the trial by the physician.

Design outcomes

Primary

MeasureTime frame
Body Mass Index(BMI);

Secondary

MeasureTime frame
Body Weight;waist;hip circumference;Waist-Hip Ratio;Abdominal acupoint subcutaneous fat thickness;Body Composition Analysis;Safety Analysis;

Countries

China

Contacts

Public ContactZhu fengya

Zigong First People's Hospital

1334662949@qq.com15983158337

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026